Ultrasound Guided Subcostal Transversus Abdominis Plane Versus

Status Completed

Clinical Trial Summary

The investigators aimed to compare the effects of perioperative anesthesia consumption of ultrasound guided subcostal transversus abdominis plane and paravertebral block in laparoscopic cholecystectomy.

Clinical Trial Description

Fifty patients aged 18 - 65 years, American Society of Anesthesiologists (ASA) I-II-III, scheduled for laparoscopic cholecystectomy were enrolled into the study. Patients were allocated into two groups to receive ultrasound guided subcostal transversus abdominis plane block (group T, n=25) or ultrasound guided paravertebral block (group P, n=25). In all patients; anesthesia was induced with iv propofol (2 mg.kg-1) and maintained with total intravenous anesthesia (TIVA) in a mixture of 50 % nitrous oxide and 50 % oxygen with a total gas flow rate of 4 L min-1. Neuromuscular relaxation was induced with iv rocuronium (0.5 mg.kg-1). Propofol (2 mg / cc, 2-4 mg / kg / h) and remifentanil (13.3 mcg / cc, 1-3 mcg / kg / h) combination was used in TIVA. Propofol and remifentanil rates increased or reduced according to the patient's hemodynamic response. Prior to start surgery, ultrasound guided subcostal transversus abdominis plane or paravertebral block was performed in patients .

Blood pressure, heart rate and peripheral oxygen saturation,TIVA consumption of 0, 5, 10, 15, 30, 60 min were recorded for all patients.Before the end of surgery, tramadol was administered (2 mg / kg) for all patients.

All patients were evaluated at postoperative 2th, 4th, 8th, 12th, 24th hours with; operation time, heart rate, blood pressure, peripheral oxygen saturation, visual pain scores (VAS), analgesic consumption, complications (hypotension, anaphylaxis, hematoma, IV injection, intra-abdominal organ injury, pneumothorax ) and patient satisfaction status were recorded. In the postoperative period if there is additional analgesic requirements (VAS≥4) tramadol 2 mg.kg-1 was administered as IV. The first hour is needed analgesia were recorded. ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment

Related Conditions & MeSH terms

Cholecystitis

Clinical Trial Details

NCT number	NCT02379780
Study type	Interventional
Source	Cukurova University
Contact
Status	Completed
Phase	N/A
Start date	September 2014
Completion date	February 2015

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT03636841` - Reduction of Operating Time by a Smoke Electroprecipitation Device for Acute Cholecystitis	N/A
Completed	`NCT02264444` - Establishing Visualization Grading Scale on LESS Cholecystectomy	N/A
Completed	`NCT02461147` - Prospective Validation of "Cholecystectomy First" Strategy for Gallstone Migration
Completed	`NCT01937104` - ONSD According to the Position During Laparoscopy	N/A
Completed	`NCT01476995` - Prognostic Indicators as Provided by the EPIC ClearView	N/A
Completed	`NCT00940264` - Laparoscopic Transvaginal Hybrid Cholecystectomy: a Prospective Data Collection.	N/A
Completed	`NCT00746850` - Harmonic in Laparoscopic Cholecystectomy for Acute Cholecystitis	N/A
Completed	`NCT00370344` - Small-incision Open Cholecystectomy or Laparoscopic Cholecystectomy for Gallbladder Disease	Phase 2/Phase 3
Completed	`NCT00195351` - Study Comparing Tigecycline Versus Ceftriaxone Sodium Plus Metronidazole in Complicated Intra-abdominal Infection	Phase 4
Completed	`NCT02858986` - 3D Versus 4K Laparoscopic Cholecystectomy	N/A
Completed	`NCT04602156` - US-guided Trocar Versus Seldiger Technique for Percutaneous Cholecystostomy	N/A
Completed	`NCT04942665` - Low Dose ICG for Biliary Tract and Tumor Imaging	Phase 2
Completed	`NCT02547064` - Effect of Modified Stylet Angulation on the Intubation With GlideScope®	N/A
Completed	`NCT00230971` - Study Comparing Tigecycline Versus Ceftriaxone Sodium Plus Metronidazole in Complicated Intra-abdominal Infection (cIAI)	Phase 4
Completed	`NCT04122261` - A Clinical Study of Chinese Domestic Surgical Robot	N/A
Completed	`NCT04716166` - Incentive Spirometry and Upper Abdominal Laparoscopic Surgery	N/A
Completed	`NCT01476319` - Improving Informed Consent Process for Percutaneous Cholecystostomy in the Emergency Department	N/A
Withdrawn	`NCT02225418` - Transmuscular Quadratus Lumborum Block for Laparoscopic Cholecystectomy	N/A
Suspended	`NCT04306939` - Genomic Resources for Enhancing Available Therapies (GREAT1.0) Study
Completed	`NCT02782832` - No Need for Neuromuscular Blockade in Daycase Laparoscopic Surgery

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Ultrasound Guided Subcostal Transversus Abdominis Plane Versus Paravertebral Block in the Laparoscopic Cholecystectomy

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms